• Saranda Bekteshi, Elegast Monbaliu, Sarah McIntyre, Gillian Saloojee, Sander R Hilberink, Nana Tatishvili, and Bernard Dan.
• Neurorehabilitation Technology Lab, Department of Rehabilitation Sciences, KU Leuven, Campus Bruges, Bruges, Belgium.
• Lancet Neurol. 2023 Mar 1; 22 (3): 229243229-243.

AbstractCerebral palsy is a lifelong neurodevelopmental condition arising from non-progressive disorders occurring in the fetal or infant brain. Cerebral palsy has long been categorised into discrete motor types based on the predominance of spasticity, dyskinesia, or ataxia. However, these motor disorders, muscle weakness, hypotonia, and impaired selective movements should also be discriminated across the range of presentations and along the lifespan. Although cerebral palsy is permanent, function changes across the lifespan, indicating the importance of interventions to improve outcomes in motor disorders associated with the condition. Mounting evidence exists for the inclusion of several interventions, including active surveillance, adapted physical activity, and nutrition, to prevent secondary and tertiary complications. Avenues for future research include the development of evidence-based recommendations, low-cost and high-quality alternatives to existing therapies to ensure universal access, standardised cerebral palsy registers to harmonise epidemiological and clinical information, improved adult screening and check-up programmes to facilitate positive lived experiences, and phase 3 trials for new interventions.Copyright © 2023 Elsevier Ltd. All rights reserved.

22 keywords...

hide…